rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    INAB
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      IN8bio reports survival data from glioblastoma trial
      Nov 16Investing.comINAB
      IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
      Nov 6Yahoo FinanceINAB
      IN8bio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
      Nov 5Yahoo FinanceINAB
      IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
      Oct 6Yahoo FinanceINAB
      IN8bio at Sidoti Small-Cap Virtual Conference: gamma-delta push
      Sep 24Investing.comINAB
      IN8bio to Present at Sidoti Small-Cap Virtual Conference

      NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced that William Ho, Chief Executive Officer and Co-Founder, will participate in the Sidoti Small-Cap Virtual Conference, held September 23-24, 2026. Mr. Ho will participate in one-on-one meetings with investors throughout the conference and deliver a company

      Sep 22Yahoo FinanceINAB
      IN8bio at H.C. Wainwright conference: gamma delta bets gain traction
      Sep 14Investing.comINAB
      IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
      Sep 10Yahoo FinanceINAB
      IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
      Sep 9Yahoo FinanceINAB

      This is the newest page. Registered accounts read further back.